680 likes | 825 Views
Interventional Registries. The Audit and Research Potential of the BCIS CCAD Registry Peter F Ludman. NO CONFLICT OF INTEREST TO DECLARE. Audit: Background. Clinical Governance The systematic approach to maintaining and improving the quality of patient care in a health system
E N D
Interventional Registries The Audit and Research Potential of the BCIS CCAD Registry Peter F Ludman
Audit: Background • Clinical Governance • The systematic approach to maintaining and improving the quality of patient care in a health system • Recognisably high standards of care • Transparent responsibility and accountability for those standards • A constant dynamic of improvement
Clinical Governance • Education and training • continued professional development • Clinical effectiveness • the appropriateness, efficacy, cost effectiveness and safety of different therapies. • Research and development • the application of new research findings into clinical practice and guideline development. • Openness • Poor practice can thrive if it occurs out of the scrutiny of peers, and while openness is important, it must respect appropriate individual patient and practitioner confidentiality. • Risk management • addressing and minimising risks to patients, physicians and organisations. • Clinical audit
Clinical Audit • Greatest potential to assess quality of care • Domains • Structure • Appropriateness • Process • Outcomes
BPEG SCTS British Paediatric Cardiac Association Aim: Harmonise datasets Design medical audit system Based on principles of quality assurance To be used Nationally 6 Specialist Groups CCAD formed May 1996 DoH funding Pilot for 3 years 1999 onwards Funding via NHS IA
Data Collection Spreadsheet • BCIS-CCAD dataset 5.5.6 (113 fields) csv file spec
CCAD Mechanism Hospital 1 encryption Hospital 2 encryption Internet CCAD Server Hospital 3 encryption . . Hospital n encryption
Central Cardiac Audit Database Domains Heart Valve registry
Central Cardiac Audit Database Domains Heart Valve registry
Procedure Specific AnalysisParticipation inCCAD 2009 data: Ludman
CCAD dataUK PCI data in CCAD as % of Reported Totals 2009 data: Ludman As August 2010
CCAD dataUK PCI data in CCAD as % of Reported Totals 2009 data: Ludman As August 2010
% Completeness12 fields required for risk adjusted outcome NWQIP Top score potential = 1200
2009 2006 2007 2008
Audit Potential • Structure • Appropriateness • Process • Outcome
Audit Potential • Structure • Appropriateness • Process • Outcome
No PPCI Angiography (76) PCI (105) PPCI day PPCI 24/7
No PPCI Angiography (76) PCI (105) PPCI day PPCI 24/7
Audit Potential • Structure • Appropriateness • Process • Outcome
2009 data: Ludman Primary PCI - ? Case selection% Cases over 80 (2009 data) % of cases with age over 80 yrs 11.7% Number of PPCI procedures
2009 data: Ludman Primary PCI - ? Case selection% Cases over 80 (2009 data) % of cases with age over 80 yrs 11.7% Number of PPCI procedures
2008 data: Ludman Appropriateness Under analysis Accepted as appropriate
2008 data: Ludman Appropriateness Acute
2008 data: Ludman Appropriateness
2008 data: Ludman Appropriateness
2008 data: Ludman Appropriateness
2008 data: Ludman Appropriateness
2008 data: Ludman Appropriateness
2008 data: Ludman Appropriateness
2008 data: Ludman Appropriateness • Stable • CCS 0/1 • no non invasive testing • no invasive testing for ischaemia
Audit Potential • Structure • Appropriateness • Process • Outcome
Primary PCI Admitted from the community D1 Admission to Non-PCI centre D2 Direct admission to PCI centre Transfer to PCI centre device
Primary PCIDirect and IHT:Call to Balloon times < 150 min 2009 data: Ludman 75.3% 3 SD 3 SD 2 SD 2 SD % CTB < 150 min Number of Cases
Audit Potential • Structure • Appropriateness • Process • Outcome
2009 data: Ludman Outcome 2009 *all PPCI (includes shock / ventilation etc)
2009 data: Ludman Primary PCI (includes shock/vent)30 day ONS tracked Mortality % Mortality at 30 days 6.2% Shock and ventilation INCLUDED Number of PPCI procedures
NWQIP Model 2009 data: Ludman Observed MACCE Predicted MACCE +3 σ +2 σ -2 σ -3 σ
Live view in Lotus Notes emailed reports Annual reports Feedback to units
National PCI Unit
National 60% 35% 0.9% QEB 66% 55% 2.0%
Audit Research
Audit Research RCT Registry
Randomised Control Trials Strengths Randomisation Ability to test hypotheses Cause and effect conclusions Precise and robust analysis Weakness Focused entry criteria costs limit patient number and FU duration ESC STEMI Guidelines 13% based on RCTs (Tricoci P JAMA 2009;301:831) Euro Heart Survey up to 89% wld be excluded from RCTs (Hordijk_Trion M EHJ 2006;27:671)
Registry • Strengths • Generalised entry • full spectrum including high risk patients included • Population outcomes • Long follow up • Large numbers of patient assessed • Suited to Risk Modelling • Weaknesses • Non randomised • Observational • Hypothesis generating (cause v effect uncertain)
SCAAR scare James S. EuroInt 2009;5:501 ? 32% Mortality
SCAAR scare James S. EuroInt 2009;5:501